Stents: Cook Medical gets panel date for Zilver
September 12, 2011 by MassDevice staff
The FDA's circulatory system devices advisory panel will review Cook's pre-market approval application for its Zilver-PTX stent on October 13.
Cook Medical will finally get its date with the FDA about the future of its drug-eluting stent for the treatment of peripheral arterial disease (PAD).
After over a year in the works, the federal watchdog agency's circulatory system devices advisory panel will review Cook Medical's pre-market approval application for its Zilver-PTX system on October 13. Cook filed its PMA application in June 2010. It has had CE Mark approval for sales in Europe since 2009.
Sign up to get our free newsletters delivered right to your inbox.
With FDA, Cook will be competing directly over the U.S. PAD market with medical device giant Medtronic, Inc. (NYSE:MDT)
Similar entries
"Between the U.S. and Europe, PAD affects almost 27 million people. It is a very serious condition. Your five-year survivability with PAD is worse than several cancers, including colon cancer. It's actually worse than if you have a heart attack," Rob Lyles, vice president & global leader of Cook Medical's peripheral intervention unit told MassDevice last year. "There's tremendous patient need there."
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
Medical device tax: Consultant calls offshoring concerns 'horse hockey'
Concerns that the medical device tax will push companies to lay off workers and move operations...
FDA clears OrthoSensor's Verasense knee replacement device
The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical wins CE Mark for peripheral catheter
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
Recalls: FDA makes Endologix catheter introducer recall Class I
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
pSivida gains big on buyout rumor
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
